首页> 外文期刊>Journal of Neurology, Neurosurgery and Psychiatry >A predictive value of hyponatremia for poor outcome and cerebral infarction in high-grade aneurysmal subarachnoid haemorrhage patients.
【24h】

A predictive value of hyponatremia for poor outcome and cerebral infarction in high-grade aneurysmal subarachnoid haemorrhage patients.

机译:低钠血症对高度动脉瘤性蛛网膜下腔出血患者预后不良和脑梗死的预测价值。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The clinical significance of hyponatremia has not been investigated in high-grade aneurysmal subarachnoid haemorrhage (aSAH) patients. Thus, we assessed the predictive value of hyponatremia for poor outcome or cerebral infarction in high grade patients (the World Federation of Neurological Surgeons Scale (WFNS) grade 4 or 5) after aSAH. METHODS: Patients with WFNS grade 4 or 5 after aSAH were selected into this study between January 2005 and January 2008. In the same period, patients with WFNS grade 1, 2 or 3 after aSAH (low grade) were also chosen into this study. Hyponatremia was determined with serum sodium measurements obtained within 9 days after aSAH. Prognosis of patients was estimated with Glasgow Outcome Scale at 3 months. The relationship between hyponatremia and poor outcome and association of hyponatremia and cerebral infarction were analysed, respectively. RESULTS: A total of 124 high-grade patients were included in this study. Of those, 78 patients developed hyponatremia. Hyponatremia developed in 32.3% of cases between days 1 and 3 after aSAH, and 30.6% developed hyponatremia after 3 days post-aSAH. Multivariable analysis revealed that hyponatremia was not correlated with poor outcome in high-grade aSAH patients. Furthermore, only late-onset hyponatremia was correlated with cerebral infarction in these patients. Meanwhile, there was no significant correlation between hyponatremia and poor outcome or cerebral infarction in 259 low-grade aSAH patients. CONCLUSIONS: Hyponatremia does not predict poor outcome in all-grade aSAH patients. However, late-onset hyponatremia in high-grade aSAH patients is associated with cerebral infarction. Therefore, the appropriate management of hyponatremia could be beneficial in those patients.
机译:背景:尚未对高级别动脉瘤性蛛网膜下腔出血(aSAH)患者的低钠血症的临床意义进行研究。因此,我们评估了aSAH后高级别患者(世界神经外科医师联合会量表(WFNS)等级4或5)对低钠血症对不良结局或脑梗塞的预测价值。方法:2005年1月至2008年1月,选择aSAH后WFNS为4或5级的患者。同一时期,aSAH后(低级)为WFNS 1、2或3级的患者也入选本研究。用aSAH后9天内获得的血清钠含量测定低钠血症。使用格拉斯哥结果量表评估患者的预后3个月。分析了低钠血症与预后不良之间的关系,以及低钠血症与脑梗死的关系。结果:本研究共纳入124名高等级患者。其中,78名患者发生了低钠血症。在aSAH后的第1天至第3天,低钠血症发生率达到32.3%,在aSAH后的3天后发生低钠血症的率为30.6%。多变量分析显示,低钠血症与高级别aSAH患者的不良预后无关。此外,这些患者中只有迟发性低钠血症与脑梗死有关。同时,在259例低度aSAH患者中,低钠血症与不良预后或脑梗死之间无显着相关性。结论:低钠血症不能预测所有等级aSAH患者的预后不良。但是,高度aSAH患者的迟发性低钠血症与脑梗死有关。因此,适当的处理低钠血症可能对那些患者有益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号